Thomas Powles
MBBS, MD
Director, Barts Cancer Centre
👥Biography 个人简介
Thomas Powles is a global leader in urothelial cancer who has led transformative clinical trials of enfortumab vedotin and checkpoint immunotherapy. He was principal investigator of the EV-302 trial establishing enfortumab vedotin plus pembrolizumab as first-line standard of care for advanced urothelial carcinoma. His research has fundamentally reshaped the bladder cancer treatment landscape.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thomas Powles 的研究动态
Follow Thomas Powles's research updates
留下邮箱，当我们发布与 Thomas Powles（Barts Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment